MIM
SGMO

MetLife Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

MetLife Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-67,978
Closed -$40.8K – 2860
2023
Q3 		$40.8K Hold
67,978
– – ﹤0.01% 2846
2023
Q2 		$88.4K Hold
67,978
– – ﹤0.01% 2747
2023
Q1 		$120K Buy
67,978
+12,905
+23% +$36.8K ﹤0.01% 2477
2022
Q4 		$173K Sell
55,073
-11,761
-18% -$45.6K ﹤0.01% 2337
2022
Q3 		$327K Hold
66,834
– – ﹤0.01% 1934
2022
Q2 		$277K Buy
66,834
+7,166
+12% +$31K ﹤0.01% 2076
2022
Q1 		$347K Buy
59,668
+15,097
+34% +$89.8K ﹤0.01% 2004
2021
Q4 		$334K Hold
44,571
– – ﹤0.01% 1739
2021
Q3 		$402K Hold
44,571
– – ﹤0.01% 1654
2021
Q2 		$534K Hold
44,571
– – ﹤0.01% 1533
2021
Q1 		$558K Sell
44,571
-8,357
-16% -$113K 0.01% 1461
2020
Q4 		$826K Hold
52,928
– – 0.01% 1220
2020
Q3 		$500K Hold
52,928
– – 0.01% 1368
2020
Q2 		$474K Hold
52,928
– – 0.01% 1407
2020
Q1 		$337K Hold
52,928
– – ﹤0.01% 1429
2019
Q4 		$443K Hold
52,928
– – ﹤0.01% 1533
2019
Q3 		$479K Hold
52,928
– – 0.01% 1442
2019
Q2 		$570K Buy
52,928
+5,771
+12% +$61.4K 0.01% 1401
2019
Q1 		$450K Hold
47,157
– – ﹤0.01% 1515
2018
Q4 		$541K Hold
47,157
– – 0.01% 1322
2018
Q3 		$799K Hold
47,157
– – 0.01% 1242
2018
Q2 		$670K Buy
47,157
+7,971
+20% +$132K 0.01% 1225
2018
Q1 		$745K Hold
39,186
– – 0.01% 1143
2017
Q4 		$643K Buy
+39,186
New +$583K 0.01% 1259

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MetLife Investment Management's SGMO Position: Q4 2023 in Review

MetLife Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2023, closing a stake of 67,978 shares — an estimated $40.8K sold.

MetLife Investment Management first reported a position in SGMO in Q4 2017 and held it in 24 quarters. The position peaked at $826K in Q4 2020. 130 funds tracked by Wall St. Rank hold SGMO as of Q4 2023.

  • MetLife Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 67,978 SANGAMO THERAPEUTICS INC shares in Q4 2023, an estimated $40.8K.
  • MetLife Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 24 quarters.
  • MetLife Investment Management's SANGAMO THERAPEUTICS INC position peaked at $826K in Q4 2020.
  • 130 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.